| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.15 | 5e-06 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.15 | 1e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.13 | 3e-05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0001 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0002 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |